Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
The current inactivated influenza vaccines provide satisfactory protection against homologous viruses but limited cross-protection against antigenically divergent strains. Consequently, there is a need to develop more broadly protective vaccines. The highly conserved extracellular domain of the matr...
Saved in:
| Main Authors: | Mohamed Elaish, John M Ngunjiri, Ahmed Ali, Ming Xia, Mahmoud Ibrahim, Hyesun Jang, Jagadish Hiremath, Santosh Dhakal, Yosra A Helmy, Xi Jiang, Gourapura J Renukaradhya, Chang-Won Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171174&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01) -
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
by: Jialu Zhang, et al.
Published: (2021-01-01) -
Efficacy of a nanoparticle vaccine administered in-ovo against Salmonella in broilers.
by: Keila Acevedo-Villanueva, et al.
Published: (2021-01-01) -
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens
by: Kairat Tabynov, et al.
Published: (2025-03-01) -
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
by: Zhifei Chen, et al.
Published: (2025-01-01)